• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Doloromics

Monday, June 03, 2024
CP
Pain Management
Doloromics is a leading-edge company focused on revolutionizing chronic pain management through precision medicine. We possess the most extensive multi-omic database of human sensory tissue, enabling us to create a detailed molecular map of pain-specific therapeutic targets via our proprietary Nociceptive Cartography. Our team, endowed with profound expertise in neuropharmacology, pain biology, and pharmaceutical development, is committed to discovering and developing safer, more effective analgesics. By addressing the root causes of pain across diverse chronic conditions, we aim to deliver personalized medications. Our innovative approach is supported by the DOLOReS platform, a state-of-the-art discovery engine that begins with human disease tissue analysis to uncover and validate pivotal pain drivers. At Doloromics, we're on a revolutionary mission to alleviate human suffering by transforming the pain treatment paradigm, ensuring patients receive the most targeted, effective care.
Doloromics
Company Website: http://www.doloromics.com
Lead Product in Development: mGlu5 Negative Allosteric Modulator
Number Of Unlicensed Products (For Which You Are Seeking Partners): 5

Company HQ City

Menlo Park

Company HQ State

California

Company HQ Country

United States

CEO/Top Company Official

Lucas Rodriguez

Development Phase of Primary Product

Pre-Clinical
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS